A new publication dated October 29, 2026 presents diagnostic insights from twenty years of bilateral inferior petrosal sinus sampling for Cushing disease at Mayo Clinic. The article appears in the journal Endocrine. Desmopressin is referenced in connection with this diagnostic testing context, which has an approved regulatory status. The publication is identified by PubMed ID 42955476 and is available through the listed source link.
This brief reports only that the publication exists, where it was published, and its title, as provided in the event record. No findings, outcomes, or diagnostic performance data from the study are summarized here, since none were included in the event details supplied. No efficacy or safety conclusions about desmopressin can be drawn from this listing alone.
Readers interested in the clinical and procedural context surrounding inferior petrosal sinus sampling and its use alongside desmopressin should consult the full article directly through the source link for complete details. For general background on this compound, readers can consult the compound overview provided alongside this brief.